AWP
HALO icon

Abacus Wealth Partners’s Halozyme HALO Stock Holding History

Abacus Wealth Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Sell
3,358
-3,455
-51% -$236K 0.03% 260
2026
Q1 		$440K Sell
6,813
-135
-2% -$9.52K 0.04% 250
2025
Q4 		$468K Buy
+6,948
New +$467K 0.05% 233

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Abacus Wealth Partners's HALO Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Halozyme (HALO) stake by 51% in Q2 2026, selling an estimated $236K and leaving 3,358 shares worth $263K. The position accounts for 0.03% of the portfolio, ranked #260.

Abacus Wealth Partners first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. The position peaked at $468K in Q4 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Abacus Wealth Partners held 3,358 shares of Halozyme worth $263K as of Q2 2026.
  • Abacus Wealth Partners sold 3,455 Halozyme shares in Q2 2026, an estimated $236K.
  • Halozyme made up 0.03% of Abacus Wealth Partners's portfolio in Q2 2026, its #260 holding.
  • Abacus Wealth Partners first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • Abacus Wealth Partners's Halozyme position peaked at $468K in Q4 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.